undergone transcatheter aortic valve implantation (TAVI) 6 months before admission. Inflammatory markers were increased and a chest X-ray and computed tomography (CT) showed a minimal left pleural effusion. An empirical antibiotic treatment and ibuprofen to control chest pain were started on the presumption of an acute bronchitis. Despite 15 days of different antibiotic protocols the markers of inflammation remained increased. A positron emission tomography with computed tomography and cardiac magnetic resonance imaging showed signs of an aseptic pericarditis. After having excluded any infectious, metabolic, drug-induced or neoplastic genesis we considered the diagnosis of late onset autoimmune-mediated pericarditis. Subsequently, treatment was promptly initiated with colchicine and prednisone. The patient reported clinical improvement in the following days and the CRP value continuously decreased. 
... Discussion
To the best of our knowledge, this is the first reported case of post-cardiac injury syndrome after TAVI. It should be considered in those patients who have persistent chest pain, fever, fatigue, and elevated inflammatory markers after a TAVI procedure, even though it may occur weeks or months after the intervention. A triple therapy with colchicine, ibuprofen, and low-dosage steroids may be used for persistent symptoms. 
Learning points
• To the best of our knowledge, this is the first reported case of post-cardiac injury syndrome after transcatheter aortic valve implantation (TAVI).
• Such diagnosis should be considered in those patients who have persistent chest pain, fever, fatigue, and elevated inflammatory markers after a TAVI procedure, although it may occur weeks or months after the intervention.
Introduction
The term post-cardiac injury syndromes indicate a group of inflammatory pericardial syndromes including post-myocardial infarction pericarditis, post-pericardiotomy syndrome, and post-traumatic pericarditis. 1 The immune-mediated pathogenesis is characterized by a latent period generally of a few weeks until the appearance of the first manifestations and the response to anti-inflammatory drugs (nonsteroidal anti-inflammatory drugs (NSAIDs), corticosteroids, and colchicine). 1, 2 We hereby describe a case with post-cardiac injury syndrome after transcatheter aortic valve implantation (TAVI), which is the first case reported so far.
Timeline Case presentation
A 79-year-old woman with a history of hypertension and paroxysmal atrial fibrillation presented to our department complaining of fatigue, pleuritic chest pain (worsened with deep inspiration), dyspnoea at rest, non-productive cough, and low degree fever during the last few days. The patient had undergone an uncomplicated TAVI procedure (26 mm CoreValve Evolut Bioprosthesis) due to severe symptomatic aortic stenosis 6 months before. On physical examination we documented normal heart and lung sounds on auscultation, normal jugular venous pulse, oxygen saturation of 98% on room air, a breathing rate of 22/min, temperature of 38.0 C, heart rate of 112 beats/min, and (EF) 65%]. The patient was subjected to diagnostic imaging including abdominal ultrasound, X-ray, and computed tomography of the chest. Besides a minimal left pleural effusion these imaging studies did not reveal significant pathologic findings.
The case was presented at our weekly multidisciplinary meeting with cardiology doctors, respiratory doctors, and radiologists. Following team discussions, an empirical antibiotic treatment with clarithromycin and piperacillin/tazobactam together with an antiinflammatory therapy with ibuprofen 400 mg twice daily to control chest pain were started on the presumption of an acute bronchitis. Despite 7 days of antibiotic therapy, the patient still reported no improvement of her initial symptoms. value of procalcitonin (0.05 ng/mL) remained normal. As a result, we changed the antibiotic therapy to meropenem and vancomycin. The patient's blood cultures and other examinations in medical microbiology and virology such as bacterial, viral, fungal, and parasitic infections were normal. After 11 days of antibiotic treatment, the patient developed high fever (38.5 C), increased pleuritic chest pain and malaise. The leucocytes count and CRP peaked at 19.9 Â 10 9 /L and 274.6 mg/L, respectively. We reconsidered antibiotic therapy and changed it to daptomycin, fosfomycin, and ceftazidime. A transthoracic echocardiographic examination showed a new small pericardial effusion (3 mm measured at end-diastole) extending to the right ventricular apex without signs of tamponade ( Figure 2) . A fluorodeoxyglucose positron emission tomography with computed tomography (FDG-PET/CT) showed diffused increased FDG-uptake of the pleura and the pericardium consistent with inflammatory changes (Figure 3) .
In addition, a cardiac magnetic resonance imaging (MRI) study (Figures 4 and 5) was performed demonstrating an oedematous thickening of the pleura and pericardium with increased contrast enhancement corresponding to an aseptic pericarditis without a circumferential effusion. It showed a normal left ventricular function (EF 59%) with end-systolic volume of 41 mL and end-diastolic volume of 100 mL.
We excluded any infectious, metabolic, drug-induced, or neoplastic genesis and considered the diagnosis of late onset autoimmune-mediated pericarditis after TAVI (post-cardiac injury syndrome). Therefore, treatment was immediately initiated with colchicine 0.5 mg and prednisone 20 mg daily in addition to the nonsteroidal anti-inflammatory therapy that had already been started. [1] [2] [3] The patient reported clinical improvement in the following days even though the white blood cell count remained high (likely due to prednisolone effect). The CRP value continuously decreased down to 16.8 mg/L on the day the patient was discharged ( Figure 6 ). Repeated electrocardiography controls demonstrated a normalization of PR segment changes. A chest ultrasound showed resolution of the pleural effusion. The dose of prednisolone was then reduced to 5 mg daily, and the anti-inflammatory therapy was stopped. A 3- At 3 months after discharge, the patient had no dyspnoea, no fever, and no chest pain after having taken regularly steroids and colchicine. In a follow-up visit at the local cardiologist, the presence of a minimal, haemodynamically insignificant pericardial effusion was documented.
The pleural effusions were completely resolved. Her CRP value had remained under 5 mg/L.
Discussion
Post-cardiac injury syndrome is a form of secondary pericarditis with or without pericardial effusion, which occurs as a result of injury to the heart or pericardium. 3 It was first described in the post-myocardial infarction period occurring in the weeks to months following infarction consisting of fever, pericarditis, and elevated inflammatory markers. The differential diagnosis should include pulmonary embolism, pneumonia, myocardial infarction, congestive heart failure, and possible malignancy. Disease activity can be followed with serial testing of inflammatory markers e.g. CRP and/or sedimentation rate. Echocardiography, cardiac computed tomography, PET/CT, and cardiac MRI can characterize active inflammation, oedema, pericardial thickness, and pericardial effusion. 4, 5 The majority of patients with acute pericarditis associated with pleural effusions have a benign course. Risk factors for developing recurrent pericarditis include non-use of colchicine, a persistently elevated CRP, and an incomplete response to NSAIDs. As per the current European Society of Cardiology guidelines, an anti-inflammatory therapy with aspirin or NSAIDs and colchicine is the first choice for treatment of inflammatory pericardial syndromes. Low-dose corticosteroids should be considered for persistent symptoms after an infectious cause has been excluded. 1, 6 Our patient's presentation, previous recent cardiac intervention (TAVI), lack of other identifiable cause, and prompt response to treatment suggested post-cardiac injury syndrome. According to the best of our knowledge, this is the first reported case of post-cardiac injury syndrome after TAVI.
Such diagnosis should be considered in those patients who have persistent chest pain, fever, fatigue, and elevated inflammatory markers after a TAVI procedure, after having excluded any infectious genesis prior to starting treatment, although it may occur weeks or months after the intervention.
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